Advanced search
1 file | 360.52 KB Add to list

Genetic modifiers of hypertension in soluble guanylate cyclase α1-deficient mice

(2012) JOURNAL OF CLINICAL INVESTIGATION. 122(6). p.2316-2325
Author
Organization
Abstract
Nitric oxide (NO) plays an essential role in regulating hypertension and blood flow by inducing relaxation of vascular smooth muscle. Male mice deficient in a NO receptor component, the α1 subunit of soluble guanylate cyclase (sGCα1), are prone to hypertension in some, but not all, mouse strains, suggesting that additional genetic factors contribute to the onset of hypertension. Using linkage analyses, we discovered a quantitative trait locus (QTL) on chromosome 1 that was linked to mean arterial pressure (MAP) in the context of sGCα1 deficiency. This region is syntenic with previously identified blood pressure-related QTLs in the human and rat genome and contains the genes coding for renin. Hypertension was associated with increased activity of the renin-angiotensin-aldosterone system (RAAS). Further, we found that RAAS inhibition normalized MAP and improved endothelium-dependent vasorelaxation in sGCα1-deficient mice. These data identify the RAAS as a blood pressure-modifying mechanism in a setting of impaired NO/cGMP signaling.
Keywords
BLOOD-PRESSURE REGULATION, QUANTITATIVE TRAIT LOCI, GENOME-WIDE ASSOCIATION, TGR(MREN2) 27 RATS, KNOCKOUT MICE, SMOOTH-MUSCLE-CELLS, KIDNEY-DISEASE, CONVERTING ENZYME, NITRIC-OXIDE SYNTHASE, RENIN-ANGIOTENSIN SYSTEM

Downloads

  • Genetic modifiers of hypertension in soluble guanylate cyclase a1- deficient mice.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 360.52 KB

Citation

Please use this url to cite or link to this publication:

MLA
Buys, Emmanuel S, Michael J Raher, Andrew Kirby, et al. “Genetic Modifiers of Hypertension in Soluble Guanylate Cyclase Α1-deficient Mice.” JOURNAL OF CLINICAL INVESTIGATION 122.6 (2012): 2316–2325. Print.
APA
Buys, E. S., Raher, M. J., Kirby, A., Shahid, M., Baron, D. M., Hayton, S. R., Tainsh, L. T., et al. (2012). Genetic modifiers of hypertension in soluble guanylate cyclase α1-deficient mice. JOURNAL OF CLINICAL INVESTIGATION, 122(6), 2316–2325.
Chicago author-date
Buys, Emmanuel S, Michael J Raher, Andrew Kirby, Mohd Shahid, David M Baron, Sarah R Hayton, Laurel T Tainsh, et al. 2012. “Genetic Modifiers of Hypertension in Soluble Guanylate Cyclase Α1-deficient Mice.” Journal of Clinical Investigation 122 (6): 2316–2325.
Chicago author-date (all authors)
Buys, Emmanuel S, Michael J Raher, Andrew Kirby, Mohd Shahid, David M Baron, Sarah R Hayton, Laurel T Tainsh, Patrick Sips, Kristen M Rauwerdink, Qingshang Yan, Robert ET Tainsh, Hannah R Shakartzi, Christine Stevens, Kelly Decaluwé, Maria da Gloria Rodrigues-Machado, Rajeev Malhotra, Johan Van de Voorde, Tong Wang, Peter Brouckaert, Mark J Daly, and Kenneth D Bloch. 2012. “Genetic Modifiers of Hypertension in Soluble Guanylate Cyclase Α1-deficient Mice.” Journal of Clinical Investigation 122 (6): 2316–2325.
Vancouver
1.
Buys ES, Raher MJ, Kirby A, Shahid M, Baron DM, Hayton SR, et al. Genetic modifiers of hypertension in soluble guanylate cyclase α1-deficient mice. JOURNAL OF CLINICAL INVESTIGATION. 2012;122(6):2316–25.
IEEE
[1]
E. S. Buys et al., “Genetic modifiers of hypertension in soluble guanylate cyclase α1-deficient mice,” JOURNAL OF CLINICAL INVESTIGATION, vol. 122, no. 6, pp. 2316–2325, 2012.
@article{2138459,
  abstract     = {Nitric oxide (NO) plays an essential role in regulating hypertension and blood flow by inducing relaxation of vascular smooth muscle. Male mice deficient in a NO receptor component, the α1 subunit of soluble guanylate cyclase (sGCα1), are prone to hypertension in some, but not all, mouse strains, suggesting that additional genetic factors contribute to the onset of hypertension. Using linkage analyses, we discovered a quantitative trait locus (QTL) on chromosome 1 that was linked to mean arterial pressure (MAP) in the context of sGCα1 deficiency. This region is syntenic with previously identified blood pressure-related QTLs in the human and rat genome and contains the genes coding for renin. Hypertension was associated with increased activity of the renin-angiotensin-aldosterone system (RAAS). Further, we found that RAAS inhibition normalized MAP and improved endothelium-dependent vasorelaxation in sGCα1-deficient mice. These data identify the RAAS as a blood pressure-modifying mechanism in a setting of impaired NO/cGMP signaling.},
  author       = {Buys, Emmanuel S and Raher, Michael J and Kirby, Andrew and Shahid, Mohd and Baron, David M and Hayton, Sarah R and Tainsh, Laurel T and Sips, Patrick and Rauwerdink, Kristen M and Yan, Qingshang and Tainsh, Robert ET and Shakartzi, Hannah R and Stevens, Christine and Decaluwé, Kelly and Rodrigues-Machado, Maria da Gloria and Malhotra, Rajeev and Van de Voorde, Johan and Wang, Tong and Brouckaert, Peter and Daly, Mark J and Bloch, Kenneth D},
  issn         = {0021-9738},
  journal      = {JOURNAL OF CLINICAL INVESTIGATION},
  keywords     = {BLOOD-PRESSURE REGULATION,QUANTITATIVE TRAIT LOCI,GENOME-WIDE ASSOCIATION,TGR(MREN2) 27 RATS,KNOCKOUT MICE,SMOOTH-MUSCLE-CELLS,KIDNEY-DISEASE,CONVERTING ENZYME,NITRIC-OXIDE SYNTHASE,RENIN-ANGIOTENSIN SYSTEM},
  language     = {eng},
  number       = {6},
  pages        = {2316--2325},
  title        = {Genetic modifiers of hypertension in soluble guanylate cyclase α1-deficient mice},
  url          = {http://dx.doi.org/10.1172/JCI60119},
  volume       = {122},
  year         = {2012},
}

Altmetric
View in Altmetric
Web of Science
Times cited: